Synthesis and in vitro anticancer activity of brevifoliol derivatives substantiated by in silico approach
详细信息 查看全文
- 作者：Ranjeet Kaur (1)
Sunil K. Chattopadhyay (1)
Arnab Chatterjee (1)
Om Prakash (2)
Feroz Khan (2)
Nitasha Suri (3)
Dev Priya (3)
A. K. Saxena (3) - 关键词：Taxus wallichiana ; Brevifoliol derivatives ; Cytotoxicity ; In silico anticancer activity prediction
- 刊名：Medicinal Chemistry Research
- 出版年：2014
- 出版时间：September 2014
- 年：2014
- 卷：23
- 期：9
- 页码：4138-4148
- 全文大小：2,042 KB
- 参考文献：1. Alushin GM, Ramey VH, Pasqualato S, Ball DA, Grigorieff N, Musacchio A, Nogales E (2010) The Ndc80 kinetochore complex forms oligomeric arrays along microtubules. Nature 467:805鈥?10 CrossRef
2. Appendino G, Barboni L, Gariboldi P, Bombordelli E, Gabetta B, Viterbo D (1993) Revised structure of brevifoliol and some baccatin VI derivatives. J Chem Soc Chem Commun 33:1587鈥?589 CrossRef
3. Baloglu E, Kingston DGI (1999) The taxane diterpenoids. J Nat Prod 62:1448鈥?472 CrossRef
4. Balza F, Tachibana S, Barrios H, Towers GHN (1991) Brevifoliol, a taxane from / Taxus brevifolia. Phytochemistry 30:1613鈥?614 CrossRef
5. Chattopadhyay SK, Tripathi S, Darokar MP, Faridi U, Sisodia B, Negi S, Kumar JK, Khanuja SPS (2008) Syntheses and cytotoxicities of the analogues of the taxoid brevifoliol. Eur J Med Chem 43:1499鈥?505 CrossRef
6. Georg GI, Gollapudi SR, Grunewald GL, Gunn CW, Himes RH, Rao BK, Liang XZ, Mirhom YW, Mitscher LA, Velde DGV, Ye QM (1993a) A reinvestigation of the taxol content of Himalayan / Taxus wallichiana Zucc. and a revision of the structure of brevifoliol. Bioorg Med Chem Lett 3:1345鈥?348 CrossRef
7. Georg GI, Cheruvallath ZS, Velde DV, Ye QM, Mitscher LA, Himes RH (1993b) Semisynthesis and biological evaluation of brevifoliol 13-[ / N-benzoyl-(2鈥?em class="a-plus-plus">R,3鈥?em class="a-plus-plus">S)-3鈥?phenylisoserinate. Bioorg Med Chem Lett 3:1349鈥?350 CrossRef
8. Khanuja SPS, Kumar TRS, Garg A, Misra RK, Chattopadhyay SK, Srivastva S, Negi AS (2002) United States Patent Publication No. 20040127561 A1
9. Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A, Gray-Goodrich M, Campbell H, Mayo J, Boyd M (1991) Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 83:757鈥?66 CrossRef
10. Oberlies NH, Kroll DJ (2004) Camptothecin and taxol: historic achievements in natural products research. J Nat Prod 67:129鈥?35 CrossRef
11. Ramalingam S, Belani CP (2004) Paclitaxel for non-small cell lung cancer. Expert Opin Pharmacother 5:1771鈥?780 CrossRef
12. Roosild TP, Castronovo S (2010) Active site conformational dynamics in human uridine phosphorylase 1. PLoS ONE 5:e12741 CrossRef
13. Schiff PB, Horwitz SB (1980) Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 77:1561鈥?565 CrossRef
14. Schiff PB, Fant J, Horwitz SB (1979) Promotion of microtubule assembly in vitro by taxol. Nature 277:665鈥?67 CrossRef
15. Shi QW, Zhao YM, Si XT, Li ZP, Yamada T, Kiyota H (2006) 1-Deoxypaclitaxel and / abeo-taxoids from the seeds of / Taxus mairei. J Nat Prod 69:280鈥?83 CrossRef
16. Skehan P, Storeng R, Scudiero D, Monks A, Mohan JM, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxic assay for anticancer-drug screening. J Natl Cancer Inst 82:1107鈥?112 CrossRef
17. Sugimoto H, Oda S, Otsuki T, Hino T, Yoshida T, Shiro Y (2006) Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase. Proc Natl Acad Sci USA 103:2611鈥?616 CrossRef
18. Tremblay S, Soucy C, Towers N, Gunning PJ, Breau L (2004) Characterization of an / abeo-taxane: brevifoliol and derivatives. J Nat Prod 67:838鈥?45 CrossRef
19. Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comp Chem 31:455鈥?61
20. Wani MC, Taylor HL, Wall ME, Coggin P, McPhail AT (1971) Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumour agent from / Taxus brevifolia. J Am Chem Soc 93:2325鈥?327 CrossRef
21. Zhao Y, Guo N, Lou LG, Cong YW, Peng LY, Zhao QS (2008) Synthesis, cytotoxic activity, and SAR analysis of the derivatives of taxchinin A and brevifoliol. Bioorg Med Chem 16:4860鈥?871 CrossRef - 作者单位：Ranjeet Kaur (1)
Sunil K. Chattopadhyay (1)
Arnab Chatterjee (1)
Om Prakash (2)
Feroz Khan (2)
Nitasha Suri (3)
Dev Priya (3)
A. K. Saxena (3)
1. Process Chemistry and Technology Department, CSIR - Central Institute of Medicinal and Aromatic Plants, P.O. CIMAP, Lucknow, 226015, India
2. Metabolic and Structural Biology Department, CSIR - Central Institute of Medicinal and Aromatic Plants, P.O. CIMAP, Lucknow, 226 015, India
3. Pharmacology Division, CSIR - Indian Institute of Integrative Medicine, Jammu, India - ISSN：1554-8120
文摘
Five novel derivatives 1a, 1b, 1c, 2 and 3 of brevifoliol were synthesized. The structures of all the synthesized derivatives were established on the basis of IR, 1H NMR, 13C NMR and mass spectral data. All the five derivatives were tested for in vitro cytotoxicity against four human cancer cell lines. The result showed that compound 1a, 1b and 1c exhibited significant inhibition of cell growth. The mechanism of action of novel glucosidated derivatives have been explored by in silico molecular docking for anticancer activity against human lung, prostate and cervix cancer cell lines. Based on reported experimental activities on human cancer cell lines, specific molecular targets (e.g. microtubule in case of human lung cancer cell line A-549; indoleamine 2,3-dioxygenase in case of prostate cancer cell lines PC-3 and DU-145 and uridine phosphorylase 1 in case of Hela cell line) have been selected for docking studies and successfully validated for anticancer activity of brevifoliol derivatives.